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Over the past two decades, heat shock proteins (HSPs) have been implicated in inﬂam-
matory responses and autoimmunity. HSPs were originally believed to maintain protein
quality control in the cytosol. However, they also exist extracellularly and appear to act
as inﬂammatory factors. Recently, a growing body of evidence suggested that the other
class of stress proteins such as, endoplasmic reticulum (ER) stress proteins, which orig-
inally act as protein quality control factors in the secretory pathway and are induced by
ER stress in inﬂammatory lesions, also participate in inﬂammation and autoimmunity. The
immunoglobulin heavy-chain binding protein (Bip)/glucose-regulated protein 78 (GRP78),
calnexin, calreticulin, glucose-regulated protein 94 (GRP94)/gp96, oxygen regulated pro-
tein 150 (ORP150)/glucose-regulated protein 170 (GRP170), homocysteine-induced ER
protein (Herp) and heat shock protein 47 (hsp47)/Serpin H1, which are expressed not
only in the ER but also occasionally at the cell surface play pathophysiological roles in
autoimmune and inﬂammatory diseases as pro- or anti-inﬂammatory factors. Here we
describe the accumulating evidence of the participation of ER stress proteins in autoim-
munity and inﬂammation and discuss the critical differences between the two classes of
stress proteins.
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INTRODUCTION
Inﬂammation is a typical sign of autoimmune diseases. Misdi-
rected immune responses target self-antigens and induce severe
inﬂammatory responses, which sometimes cause death. In addi-
tion to numerous components in autoimmune responses, heat
shock proteins (HSPs) have been implicated in autoimmune and
inﬂammatory diseases over the past two decades (Hauet-Broere
et al., 2006; Van Eden et al., 2007). Many HSPs are so-called mol-
ecular chaperones and folding enzymes, which maintain protein
folding in a cell (Bukau et al., 2006; Hartl, 2011). Because pro-
tein folding is easily impaired by various cytotoxic stresses, such
as heat shock, cytotoxic chemicals, hypoxia, and inﬂammation,
prokaryotic to higher eukaryotic organisms have evolved stress
responses and HSPs. The transcription of HSPs and their sub-
sequent protein expression are stimulated by cytotoxic stresses,
and they immediately restore protein folding and cellular home-
ostasis to counter toxic stresses (Morimoto, 1998). Thus, HSPs
could be postulated to act as intracellular protein homeostasis
maintenance factors. However, HSPs have also been reported to
be observed in the extracellular ﬂuid (Njemini et al., 2011), and
act as pro- and anti-inﬂammatory factors especially in autoim-
mune and inﬂammatory diseases in diverse manners. In inﬂam-
matory lesions, HSPs are upregulated by inﬂammatory stress and
are released into the extracellular ﬂuid. Then, the extracellular
HSPs speciﬁcally induce proinﬂammatory cytokines and enhance
the antigenicity of autoantigens through modulations of antigen
presentation (Multhoff, 2006; Yokota and Fujii, 2010). However,
the extracellular HSPs can also stimulate anti-inﬂammatory reg-
ulatory T cell responses, thereby inducing the negative feedback
control of inﬂammation (Hauet-Broere et al., 2006;VanEden et al.,
2007). Indeed, immunization with HSP peptides prevents disease
development in autoimmune model animals, such as adjuvant
arthritis and collagen-induced arthritis (CIA; van Eden et al., 1988;
Jorgensen et al., 1998; Wendling et al., 2000). Presently, besides
HSPs, another class of stress proteins is also known to exist in
eukaryotic cells. Endoplasmic reticulum (ER) stress proteins, the
specialized factors involved in protein quality control in the secre-
tory pathway (Hoseki et al., 2010; Araki and Nagata, 2011; Smith
et al., 2011), are induced by ER stress, which is very different from
cytosolic stress (Mori, 2000;Walter and Ron, 2011). However, sim-
ilar to HSPs, ER stress proteins are also induced by inﬂammatory
stress (Yoshida, 2007), suggesting that ER stress proteinsmight also
participate in autoimmune and inﬂammatory responses. Here,
we discuss the accumulating evidence that ER stress proteins and
their autoantibodies play roles in autoimmune and inﬂammatory
diseases.
REGULAR FUNCTIONS OF ER STRESS PROTEINS
Before discussing the relevance of ER stress proteins in autoim-
mune diseases, we have brieﬂy sketched the regular functions of
ER stress proteins in a cell. Although the boundary between the
two is ambiguous, ER stress proteins can be classiﬁed into two
groups. The ﬁrst group consists of molecular chaperones and
folding enzymes, which assist the folding and assembly of newly
synthesized proteins and prevent misfolding and aggregation of
preexisting proteins. The other group consists of protein degrada-
tion factors,whichmediate the clearance of proteins that should be
degraded, such as misfolded proteins. The latter protein clearance
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pathway is called the ER-associated degradation (ERAD) pathway
(McCracken and Brodsky, 1996; Brodsky and McCracken, 1997).
The ER is located at the starting point of the protein secretory
pathway. Secretory or membrane proteins are ﬁrst cotranslation-
ally transported into the ER from cytosolic ribosomes, modiﬁed
and properly folded, and then translocated to the next step of the
secretory pathway (Figures 1A,B; Ni and Lee, 2007; Araki and
Nagata, 2011). After the ER, proteins pass through the Golgi appa-
ratus and are ﬁnally secreted to the cell surface through a secretory
vesicle. In the ER, most proteins are glycosylated and covalently
crosslinked with disulﬁde bonds. Such protein modiﬁcations are
believed necessary for the structural stabilization of the proteins
destined to be secreted into the extracellular environment (Ni and
Lee, 2007; Araki and Nagata, 2011). Calnexin and calreticulin are
lectin-like chaperones that speciﬁcally maintain the folding of gly-
cosylated proteins (Williams, 2006). Protein disulﬁde isomerase
(PDI) is an oxidoreductase that mediates protein disulﬁde bond
formation and isomerization (Tu and Weissman, 2004; Ellgaard
and Ruddock, 2005). The immunoglobulin heavy-chain binding
protein (Bip)/glucose-regulated protein 78 (GRP78) is a hsp70-
type molecular chaperone that maintains protein folding (Ni and
Lee, 2007; Araki and Nagata, 2011). Glucose-regulated protein 94
(GRP94)/gp96 and oxygen regulated protein 150 (ORP150) are
hsp90 and hsp70 family molecular chaperones, respectively; their
functions remain unclear (Ni and Lee, 2007; Araki and Nagata,
2011). Another characteristic stress protein in the ER is heat
shock protein 47 (hsp47)/Serpin H1, the only heat shock regulated
protein in the ER, is the collagen-speciﬁc molecular chaperone
(Nagata, 2003; Ishida and Nagata, 2011). Using these molecular
chaperones and folding enzymes, secretory and membrane pro-
teins are properly folded in the ER and then transported to the
Golgi apparatus. Other chaperones and enzymes were precisely
described in a recent article (Araki and Nagata, 2011).
Improperly folded proteins are strictly retained in the ER via
anchoring by ER chaperones and enter the ERAD pathway (Araki
and Nagata, 2011; Smith et al., 2011). ERAD is a multi-step mech-
anism, which can be divided into the following three steps: (1) the
substrate is recognized and isolated, (2) the substrate is dislocated
from the ER into the cytosol, and (3) the substrate is then degraded
by the ubiquitin proteasome system in the cytosol (Figures 1C–E;
Hershko and Ciechanover, 1998). Thereby, the clearance of the
proteins from the ER is completed. Among these steps, the ﬁrst
step is mediated by ERAD-enhancing mannosidase-like protein 1
(EDEM-1), ERdj5, Bip,Osteosarcoma 9 (OS9),XTP3 transactivat-
ing gene B (XTP3B), and SEL1L (Hosokawa et al., 2001; Ushioda
et al., 2008; Hagiwara et al., 2011; Ushioda and Nagata, 2011).
The substrate is directly transferred from the calnexin/calreticulin-
mediated folding cycle to the EDEM-1-containing degradation
recognition complex (Molinari et al., 2003; Oda et al., 2003).
The substrate is then transferred from EDEM-1 and SEL1L to
the so-called ERAD complex, postulated to form a protein dis-
location channel (Mueller et al., 2006, 2008; Christianson et al.,
FIGURE 1 | Schematic representation of endoplasmic reticulum (ER)
protein folding and ER-associated degradation (ERAD). Secretory and
membrane proteins are cotranslationally transported into the ER by
cytosolic ribosomes. Newly synthesized unfolded polypeptide are then
captured by molecular chaperones and protein folding enzymes (A), which
involve immunoglobulin heavy-chain binding protein (Bip), calnexin,
calreticulin, protein disulﬁde isomerase (PDI) and heat shock protein 47
(hsp47), and are properly folded. The folded polypeptides are transported
into the Golgi apparatus through transporting machinery (B). However, the
proteins that are improperly folded are speciﬁcally recognized and isolated
by ERAD recognition machinery (C), which involves ERAD-enhancing
mannosidase-like protein (EDEM), ERdj5, Bip, SEL1L, osteosarcoma 9
(OS9), and XBP1. The misfolded proteins are then transferred to the
dislocation machinery (D), which involves HRD1, Derlin, Herp, and p97.
Then, the proteins are dislocated into the cytosol through a putative
narrow pore. The dislocated proteins are ubiquitinated by ERAD ubiquitin
ligases, such as HRD1, and are ﬁnally degraded by huge cytosolic protease
complexes, the proteasome (E), into peptides.
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2008). ER stress proteins, such as HRD1/synoviolin, Derlin, and
homocysteine-induced ER protein (Herp), are involved in this
supramolecular complex (Lilley and Ploegh, 2004, 2005;Oda et al.,
2006). The substrate is then dislocated into the cytosol from the
ER. During dislocation, the substrate is ubiquitinated by the ER
ubiquitin ligase and pulled by p97/VCP from the cytosolic side
(Ye et al., 2001, 2003; Tsai et al., 2002). Finally, in the third step,
the ubiquitinated substrate is degraded by the cytosolic complex
protease, the proteasome. Detailed comprehensive descriptions of
the ERAD pathways can be found elsewhere (Araki and Nagata,
2011; Smith et al., 2011).
ER STRESS
The stress response for HSPs, called heat shock response, is medi-
ated by transcription factors called heat shock factors (HSFs;Mori-
moto, 1998). Similarly, the stress response for ER stress proteins,
called the unfolded protein response (UPR), is mediated by the
unconventional transcription factors,ATF6 andXBP1,and a trans-
lation and apoptosis regulating factor,PERK (Figure 2;Mori, 2000;
Walter and Ron, 2011). The UPR can be experimentally stimulated
by chemical compounds that speciﬁcally interfere with protein
glycosylation and disulﬁde bond formation because these protein
modiﬁcations are necessary for the structural stability of secre-
tory and membrane proteins. In addition, perturbation of calcium
storage in the ER causes impairments in the quality of ER proteins
because the ER has a high calcium concentration, and many of
the ER proteins need calcium ions. Alternatively, the UPR is phys-
iologically activated during plasma cell differentiation in order
to expand the protein folding capacity for massive production of
immunoglobulins. The activation of the UPR has been observed
in various neurodegenerative diseases, inﬂammatory diseases, and
viral infections (Yoshida, 2007). Thus, the UPR can be postulated
as a completely independent pathway from cytosolic stresses. Both
cytosolic and ER stresses are commonly stimulated by inﬂamma-
tion. Although several studies suggest that ER stress protein levels
correlate with inﬂammatory pathogenesis, the roles of ER stress
and ER stress proteins in autoimmune and inﬂammatory diseases
remain unclear. Thus, in addition to the heat shock response, the
other axis of the cellular stress responsemight provide new insights
into disease mechanisms and clinical treatments.
BIP/GRP78
The 68-kDa glycoprotein was identiﬁed through exploration of
autoantigens that predominantly immunoreact with sera from
rheumatoid arthritis (RA) patients and thus expected to be asso-
ciated with RA pathogenesis (Blass et al., 1995, 1997, 1998). Sub-
sequently, the 68-kDa antigen was demonstrated to be identical to
the ER resident hsp70 family chaperone Bip (Blass et al., 2001;Cor-
rigall et al., 2001). This crucial ER resident stress protein appears
to be expressed at the cell surface and acts as an autoantigen
in RA. Indeed, 30–75% of RA patients exhibit Bip overexpres-
sion in synovial ﬂuid or autoantibodies to Bip in serum (Blass
et al., 2001; Corrigall et al., 2001; Shoda et al., 2011). Although
the exact roles of extracellular Bip and anti-Bip autoantibodies in
RA pathogenesis remain debatable, three possible functions can
be considered. First, extracellular Bip and its antibody may result
FIGURE 2 | Schematic representation of two distinct stress responses.
When misfolded proteins accumulate in the ER, they perturb ER protein
homeostasis and organelle functions. Such perturbations are called ER
stressors (A). ER stress leads to the activation of membrane spanning stress
sensors. ATF6 is a membrane spanning transcription factor that is processed
and released from the ER membrane under ER stress, and the stress signal is
then transmitted to the nucleus. IRE1 and PERK activate the transcription
factors, XBP1 and ATF4, and stimulate a stress response. Such stress
responses are called an unfolded protein response (UPR) (B). UPR leads to an
upregulation of ER stress proteins, which consist of molecular chaperones
and folding enzymes, and ERAD recognition and dislocation factors. Such
cross-membrane signal transduction is very different from the heat shock
response (HSR) (C). When the cytosolic stresses perturb the cytosolic protein
homeostasis, heat shock factor (HSF) is activated and transmits the signal
into the nucleus. Then, an upregulation of HSPs is induced. It is a challenge to
recover cytosolic protein homeostasis.
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from inﬂammatory stress during RA progression, and they might
have no pathophysiological roles. Because the UPR is stimulated
through inﬂammation and ER stress proteins, including Bip, are
subsequently induced (Yoshida, 2007), Bip could be simply a spe-
ciﬁc and abundant autoantigen in the inﬂammatory lesion that
is unrelated to RA pathogenesis. Second, the autoantigen might
act as an anti-inﬂammatory factor, similar to HSPs. Several stud-
ies suggested that extracellular Bip stimulates the production of
the anti-inﬂammatory cytokines, IL-4 and IL-10, through spe-
ciﬁc T lymphocytes (Blass et al., 2001; Corrigall et al., 2001, 2004;
Bodman-Smith et al., 2003;Brownlie et al., 2006; Panayi andCorri-
gall, 2006). Furthermore, the pre-administration of Bip protein to
mice prevents the in vivo induction of adjuvant arthritis or CIA,
both of which are well-known artiﬁcial models of autoimmune
diseases (Corrigall et al., 2001; Brownlie et al., 2006). Third, the Bip
antigen could act as a proinﬂammatory factor. Bippositively causes
immunological responses and inﬂammation. Recently, Shoda et al.
(2011) reported that in addition to the intact Bip antibody, anti-
citrullinated Bip (ctBip) antibody is frequently detected in RA
patients. The ctBip protein, but not intact Bip, enhances anti-
citrullin antibodies and worsens arthritis symptoms in a mouse
model of adjuvant arthritis. Citrullination is protein modiﬁca-
tion in which an arginine residue is converted into a citrulline
residue by a speciﬁc intracellular enzyme, peptidylarginine deim-
inase (PAD; Vossenaar et al., 2003). The anti-citrullinated pep-
tide/protein antibody (ACPA) is frequently detected inRApatients
(Vincent et al., 2005; Suzuki et al., 2007; van Venrooij et al., 2011).
Although the reasons why citrullination is frequently observed
and how it participates in RA pathogenesis remains unclear, the
relationship between stress proteins and this speciﬁc protein mod-
iﬁcation suggests an undescribed crosstalk between inﬂammatory
stress and disease-speciﬁc protein modiﬁcations in RA pathogen-
esis. In addition to RA, the anti-Bip autoantibody is also detected
in another autoimmune and inﬂammatory disease, systemic lupus
erythematosus (SLE; Casciola-Rosen et al., 1994; Weber et al.,
2010), in which its pathophysiological role remains unknown.
HSP47
Hsp47 is an ER resident molecular chaperone; it is the only
HSP in the ER. Hsp47 speciﬁcally maintains collagen biosynthesis
(Nagata, 2003; Ishida and Nagata, 2011). Its gene disruption in
mice causes signiﬁcant reductions in mature collagens in connec-
tive tissues, resulting in embryonic lethality (Nagai et al., 2000;
Marutani et al., 2004; Matsuoka et al., 2004). Several studies
showed that the levels of anti-hsp47 autoantibody are speciﬁcally
increased in RA patients (Hattori et al., 1998, 2000, 2001, 2003,
2005). However, little is known about how hsp47 and its autoanti-
body correlate with RA pathogenesis. In addition to RA, the levels
of the autoantibody to hsp47 are also increased in other autoim-
mune diseases, such as SLE, Sjögren’s syndrome (SjS), mixed
connective tissue disease (MCTD), systemic sclerosis (SSc), and
non-speciﬁc idiopathic pneumonia (Yokota et al., 2003; Fujimoto
et al., 2004; Kakugawa et al., 2008). Most of these diseases can be
considered connective tissue diseases in which an upregulation of
various types of collagen is observed. The expression proﬁles of
collagens and hsp47 are fully consistent in both healthy (Masuda
et al., 1998; Yamamura et al., 1998; Hirata et al., 1999; Yasuda et al.,
2002) and diseased conditions (Masuda et al., 1994; Naitoh et al.,
2001; Sato et al., 2008). Hsp47 might be the protein that stands at
the junction of stress, the extracellular matrix (ECM) biogenesis,
and autoimmune/connective tissue diseases.
HERP
Lupus nephritis, which is a kidney inﬂammatory disorder, is one
of the manifestations of SLE, a complex autoimmune disease.
Among the variety of autoantibodies that are detected in SLE
patients, the anti-double-strandedDNA(dsDNA) antibody,which
is a type of anti-nuclear antibody (ANA), is most characteristic of
SLE and appears to signiﬁcantly contribute to the pathogenesis of
lupus nephritis (Isenberg et al., 2007). Although administration
of dsDNA failed to initiate antibody production (Madaio et al.,
1984), nucleosome-forming dsDNA elicited the anti-dsDNA anti-
body production (Rumore and Steinman, 1990; Casciola-Rosen
et al., 1994; Voynova et al., 2005), suggesting that proteins like
histone can work as an adjuvant for enhancing the antigenicity
of dsDNA. Another possibility for anti-dsDNA antibody pro-
duction is elicitation by cross-reactive protein antigens. Several
proteins have been reported to cross-react with the anti-dsDNA
antibody (Isenberg et al., 2007). Among them, α-actinin, which is
an actin-associated protein, might be a potent candidate for the
original antigen, which evokes anti-dsDNA antibody production
(Mostoslavsky et al., 2001;Deocharan et al., 2002). However, a dys-
regulation of the negative selection of B-cell clones,which produce
autoantibodies, occurs in these diseases.
Recently, Herp was suggested as a possible cross-reactive anti-
gen of the anti-dsDNA antibody (Hirabayashi et al., 2010). Herp
is an ER resident membrane protein that is involved in the ERAD
complex and is induced by UPR (Kokame et al., 2000, 2001;
Okuda-Shimizu and Hendershot, 2007; Kny et al., 2011; Marutani
et al., 2011). Thus, Herp is an ER stress protein, can be induced
by inﬂammatory ER stress. Among the known candidates for the
original antigen of the anti-dsDNA antibody including α-actinin,
only Herp can be induced by inﬂammatory stress. Thus, Herp can
be the key component that connects inﬂammatory stress responses
and anti-dsDNA antibody production in SLE.
CALRETICULIN
The anti-Ro/SS-A antibody, which is also considered an ANA, is
one of the most studied and crucial markers in many autoimmune
diseases, such as SLE, Sjs, SSc, and RA (Anderson et al., 1962; Clark
et al., 1969; Alspaugh and Tan, 1975; Schulte-Pelkum et al., 2009;
Defendenti et al., 2011). Although it has a strong, well-established
association with autoimmune diseases, especially with neonatal
lupus, it is unclear how it participates in autoimmune diseases
(Schulte-Pelkum et al., 2009; Defendenti et al., 2011). Recently, it
was shown that the anti-Ro/SS-A antibody can be categorized into
two types, each of which speciﬁcally recognizes the 52-kDa (Ro52)
and 60-kDa (Ro60) antigens. Ro52 and Ro60 form a Ro ribonucle-
oprotein (RNP) complex with a couple of other proteins,while the
intracellular functions and pathogenic relevancies of those anti-
gens remain unclear (Schulte-Pelkumet al., 2009;Defendenti et al.,
2011).
Calreticulin is an essential ER resident lectin-like chaperone,
which is induced by ER stress (Yoshida et al., 1998; Mesaeli et al.,
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1999; Williams, 2006). Calreticulin was ﬁrst postulated as the
Ro/SS-A autoantigen (Collins et al., 1989; McCauliffe et al., 1990).
However, it was later demonstrated that calreticulin itself was not
an antigen (Lu et al., 1993; Boehm et al., 1994), but it maintained
Ro RNP complex formation through its chaperone activity and
modulated the antigenicity of the complex (Cheng et al., 1996;
Staikou et al., 2003). Although it was shown that calreticulin
was not the autoantigen for the Ro/SS-A autoantibody, the anti-
calreticulin autoantibody has been independently observed in SLE
patients (Boehm et al., 1994), complete congenital heart block
(CCHB; Orth et al., 1996), which is one of the manifestations of
SLE, and inﬂammatory bowel disease (Watanabe et al., 2006).
CALNEXIN, GRP94, AND ORP150
Calnexin is an ER resident lectin-like chaperone (Wada et al., 1991,
1997; Hebert et al., 1995; Deprez et al., 2005), which is not induced
or is only mildly induced by ER stress (Kamauchi et al., 2005). An
autoantibody to calnexin is observed in SLE patients, while its
biological relevance remains unknown (Weber et al., 2010).
GRP94 is an essential ER resident hsp90 family chaperone,
which is induced by cytosolic and ER stress (Wanderling et al.,
2007; Eletto et al., 2010). Anti-GRP94 autoantibodies have been
observed in SLE patients (Boehm et al., 1994), RA (Weber et al.,
2010), and myasthenia gravis (MG; Suzuki et al., 2011). In addi-
tion, cell surface expression of GRP94 itself is detected in patients
with type I diabetes (Pagetta et al., 2003) and in GRP94 trans-
genic mice (Liu et al., 2003). In GRP94 transgenic mice, lupus-like
autoimmune disorder and systemic inﬂammation are induced,
suggesting that extracellular GRP94 and its autoantibody have
proinﬂammatory effects in autoimmune diseases.
ORP150 is an essential ER resident hsp70 chaperone that is
induced by ER stress and hypoxia (Kitao et al., 2001; Ni and
Lee, 2007). An autoantibody to ORP150 is detected in patients
with atherosclerosis and type I diabetes (Tsukamoto et al., 1996;
Nakatani et al., 2006), but it remains unclear if they have a
pathophysiological role in autoimmune responses.
REGULATION OF ER STRESS PROTEIN DISTRIBUTION
As discussed above, the critical difference between HSPs and ER
stress proteins is based on the stress pathway they are induced
through. One is through a heat shock response, and the other is
through the UPR. However, another striking difference exists, i.e.,
HSPs are originally distributed in the cytosol. In patients with
inﬂammatory diseases, HSPs are observed in extracellular ﬂuid;
this could be due to the destruction of the plasma membrane
that accompanies stress-induced apoptosis, necrosis, and phago-
cytosis or alternative active secretion through exosomes. On the
other hand, ER stress proteins are originally located in the secre-
tory pathway. Thus, ER stress proteins can potentially be secreted
into the cell surface, after which they escape from the ER retention
mechanism. Indeed, some ER stress proteins are expressed on the
cell surface without any cell destruction, e.g., calnexin (Okazaki
et al., 2000), calreticulin (Jeffery et al., 2011), Bip (Delpino and
Castelli, 2002), GRP94 (Altmeyer et al., 1996), and hsp47 (Hebert
et al., 1999). How they escape, how they are retained, and whether
this leaky expression correlates with autoimmune pathogenesis
remains unknown. However, this apparent difference between
the two types of stress proteins might cause physiological dif-
ferences, therefore, this should be examined in autoimmune and
inﬂammatory diseases.
CONCLUSION
Several studies suggested that ER stress proteins are potent
immunomodulating components in autoimmune and inﬂam-
matory diseases. Although their pathogenic relevancies remain
unclear, some of them appear to participate in disease progres-
sion. Their inducibility by inﬂammatory stress and their original
distribution in the secretory pathway could be advantageous for
participation in autoimmune and inﬂammatory responses. Until
now, the major evidence of the involvement of ER stress proteins
in autoimmune diseases appears to be autoantigens. This situ-
ation can be compared to that of HSPs two decades ago. Since
then, much has been revealed about the functions of HSPs in
addition to being autoantigens. Because HSPs and ER stress pro-
teins share several properties as molecular chaperones, we may be
able to expect unidentiﬁed and important roles of ER stress pro-
teins in autoimmune response as well as HSPs. Indeed, another
issue of the stress proteins in autoimmune responses is their
potential immunomodulating abilities. Because chaperones can
broadly associate with other proteins, including autoantigens and
recruit antigen presentation pathway, they can work as endoge-
nous adjuvants in immune responses. In this review, we focused
on the roles of ER stress proteins as autoantigens. However, several
other issues that are related to ER stress are also important, e.g.,
HLA-B27 misfolding in ankylosing spondylitis and anti-apoptotic
function of HRD1/synoviolin in synovial cells in RA (Yoshida,
2007; Todd et al., 2008; Yagishita et al., 2008; Colbert et al., 2010).
At the moment, the features of ER stress proteins in autoimmu-
nity remain largely unclear. The potential relevance of ER stress
proteins in many autoimmune and inﬂammatory diseases makes
them potential clinical targets.
ACKNOWLEDGMENTS
We thank Dr. Shinichi Yokota (Sapporo Medical University) for
critical reading of the manuscript. This work was supported
by Grant-in-Aid for Creative Scientiﬁc Research (19G50314;
to Kazuhiro Nagata), Grant-in-Aid for Young Scientists (B)
(22710193), and Grant-in-Aid for Scientiﬁc Research on Inno-
vative Areas (23122520; to Daisuke Morito).
REFERENCES
Alspaugh, M. A., and Tan, E. M. (1975).
Antibodies to cellular antigens in
Sjogren’s syndrome. J. Clin. Invest.
55, 1067–1073.
Altmeyer, A., Maki, R. G., Feldweg,
A. M., Heike, M., Protopopov, V.
P., Masur, S. K., and Srivastava, P.
K. (1996). Tumor-speciﬁc cell sur-
face expression of the-KDEL con-
taining, endoplasmic reticular heat
shock protein gp96. Int. J. Cancer 69,
340–349.
Anderson, J. R., Gray, K. G., Beck,
J. S., Buchanan, W. W., and
Mc, E. A. (1962). Precipitating
auto-antibodies in the connective
tissue diseases. Ann. Rheum. Dis. 21,
360–369.
Araki,K., andNagata,K. (2011). Protein
folding andquality control in theER.
Cold Spring Harb. Perspect. Biol. 3.
Blass, S., Haferkamp, C., Specker, C.,
Schwochau, M., Schneider, M., and
Schneider, E. M. (1997). Rheuma-
toid arthritis: autoreactive T cells
recognising a novel 68k autoantigen.
Ann. Rheum. Dis. 56, 317–322.
Blass, S., Meier, C., Vohr, H. W.,
Schwochau, M., Specker, C., and
Burmester, G. R. (1998). The
p68 autoantigen characteristic of
www.frontiersin.org March 2012 | Volume 3 | Article 48 | 5
Morito and Nagata ER stress proteins in autoimmunity
rheumatoid arthritis is reactive
with carbohydrate epitope speciﬁc
autoantibodies.Ann.Rheum.Dis. 57,
220–225.
Blass, S., Specker, C., Lakomek, H. J.,
Schneider, E. M., and Schwochau,
M. (1995). Novel 68 kDa autoanti-
gen detected by rheumatoid arthritis
speciﬁc antibodies.Ann.Rheum.Dis.
54, 355–360.
Blass, S., Union, A., Raymackers,
J., Schumann, F., Ungethum, U.,
Muller-Steinbach, S., De Keyser, F.,
Engel, J. M., and Burmester, G. R.
(2001). The stress protein BiP is
overexpressed and is a major B and
T cell target in rheumatoid arthritis.
Arthritis Rheum. 44, 761–771.
Bodman-Smith, M. D., Corrigall, V. M.,
Kemeny, D. M., and Panayi, G. S.
(2003). BiP, a putative autoantigen in
rheumatoid arthritis, stimulates IL-
10-producing CD8-positive T cells
from normal individuals. Rheuma-
tology (Oxford) 42, 637–644.
Boehm, J., Orth, T., Van Nguyen, P.,
and Soling, H. D. (1994). Systemic
lupus erythematosus is associated
with increased auto-antibody titers
against calreticulin and grp94, but
calreticulin is not the Ro/SS-A anti-
gen. Eur. J. Clin. Invest. 24, 248–257.
Brodsky, J. L., and McCracken, A. A.
(1997). ER-associated and protea-
somemediated protein degradation:
how two topologically restricted
events came together. Trends Cell
Biol. 7, 151–156.
Brownlie, R. J., Myers, L. K., Wooley,
P. H., Corrigall, V. M., Bodman-
Smith, M. D., Panayi, G. S., and
Thompson, S. J. (2006). Treatment
of murine collagen-induced arthri-
tis by the stress protein BiP via
interleukin-4-producing regulatory
T cells: a novel function for an
ancient protein. Arthritis Rheum. 54,
854–863.
Bukau, B., Weissman, J., and Horwich,
A. (2006). Molecular chaperones
and protein quality control.Cell 125,
443–451.
Casciola-Rosen, L. A., Anhalt, G., and
Rosen, A. (1994). Autoantigens tar-
geted in systemic lupus erythemato-
sus are clustered in two popula-
tions of surface structures on apop-
totic keratinocytes. J. Exp. Med. 179,
1317–1330.
Cheng, S. T., Nguyen, T. Q., Yang, Y. S.,
Capra, J. D., and Sontheimer, R. D.
(1996). Calreticulin binds hYRNA
and the 52-kDa polypeptide compo-
nent of the Ro/SS-A ribonucleopro-
tein autoantigen. J. Immunol. 156,
4484–4491.
Christianson, J. C., Shaler, T. A., Tyler,
R. E., and Kopito, R. R. (2008). OS-9
and GRP94 deliver mutant alpha1-
antitrypsin to theHrd1-SEL1Lubiq-
uitin ligase complex for ERAD. Nat.
Cell Biol. 10, 272–282.
Clark, G., Reichlin, M., and Tomasi,
T. B. Jr. (1969). Characterization
of a soluble cytoplasmic antigen
reactive with sera from patients
with systemic lupus erythmatosus. J.
Immunol. 102, 117–122.
Colbert, R. A., Delay, M. L., Klenk, E. I.,
and Layh-Schmitt, G. (2010). From
HLA-B27 to spondyloarthritis: a
journey through the ER. Immunol.
Rev. 233, 181–202.
Collins, J. H., Xi, Z. J.,Alderson-Lang, B.
H., Treves, S., and Volpe, P. (1989).
Sequence homology of a canine
brain calcium-binding protein with
calregulin and the human Ro/SS-
A antigen. Biochem. Biophys. Res.
Commun. 164, 575–579.
Corrigall, V. M., Bodman-Smith, M. D.,
Brunst, M., Cornell, H., and Panayi,
G. S. (2004). Inhibition of antigen-
presenting cell function and stim-
ulation of human peripheral blood
mononuclear cells to express an anti-
inﬂammatory cytokine proﬁle by the
stress protein BiP: relevance to the
treatment of inﬂammatory arthritis.
Arthritis Rheum. 50, 1164–1171.
Corrigall, V. M., Bodman-Smith, M. D.,
Fife, M. S., Canas, B., Myers, L. K.,
Wooley, P., Soh, C., Staines, N. A.,
Pappin, D. J., Berlo, S. E., Van Eden,
W., Van Der Zee, R., Lanchbury, J.
S., and Panayi, G. S. (2001). The
human endoplasmic reticulum mol-
ecular chaperone BiP is an autoanti-
gen for rheumatoid arthritis and
prevents the induction of experi-
mental arthritis. J. Immunol. 166,
1492–1498.
Defendenti, C., Atzeni, F., Spina, M. F.,
Grosso,S.,Cereda,A.,Guercilena,G.,
Bollani, S., Saibeni, S., and Puttini,
P. S. (2011). Clinical and laboratory
aspects of Ro/SSA-52 autoantibod-
ies. Autoimmun. Rev. 10, 150–154.
Delpino, A., and Castelli, M. (2002).
The 78 kDa glucose-regulated pro-
tein (GRP78/BIP) is expressed on
the cell membrane, is released into
cell culture medium and is also
present in human peripheral circu-
lation. Biosci. Rep. 22, 407–420.
Deocharan, B., Qing, X., Lichauco, J.,
and Putterman, C. (2002). Alpha-
actinin is a cross-reactive renal target
for pathogenic anti-DNA antibod-
ies. J. Immunol. 168, 3072–3078.
Deprez, P., Gautschi, M., and Helenius,
A. (2005). More than one glycan is
needed for ER glucosidase II to allow
entry of glycoproteins into the cal-
nexin/calreticulin cycle.Mol. Cell 19,
183–195.
Eletto, D., Dersh, D., and Argon, Y.
(2010). GRP94 in ER quality control
and stress responses.Semin.CellDev.
Biol. 21, 479–485.
Ellgaard, L., and Ruddock, L. W. (2005).
The human protein disulphide iso-
merase family: substrate interactions
and functional properties. EMBO
Rep. 6, 28–32.
Fujimoto, M., Hamaguchi, Y., Yazawa,
N., Komura, K., Takehara, K., and
Sato, S. (2004). Autoantibodies to a
collagen-speciﬁc molecular chaper-
one, heat-shock protein 47, in sys-
temic sclerosis. Clin. Exp. Immunol.
138, 534–539.
Hagiwara, M., Maegawa, K., Suzuki, M.,
Ushioda, R., Araki, K., Matsumoto,
Y., Hoseki, J., Nagata, K., and Inaba,
K. (2011). Structural basis of an
ERAD pathway mediated by the ER-
resident protein disulﬁde reductase
ERdj5. Mol. Cell 41, 432–444.
Hartl, F. U. (2011). Chaperone-assisted
protein folding: the path to discov-
ery from a personal perspective. Nat.
Med. 17, 1206–1210.
Hattori, T., Fujisawa, T., Sasaki, K.,
Yutani, Y., Nakanishi, T., Takahashi,
K., and Takigawa, M. (1998). Iso-
lation and characterization of a
rheumatoid arthritis-speciﬁc anti-
gen (RA-A47) from a human
chondrocytic cell line (HCS-2/8).
Biochem. Biophys. Res. Commun.
245, 679–683.
Hattori, T., Kawaki, H., Kubota, S.,
Yutani, Y., De Crombrugghe, B.,
Von Der Mark, K., and Takigawa,
M. (2003). Downregulation of a
rheumatoid arthritis-related anti-
gen (RA-A47) by ra-a47 antisense
oligonucleotides induces inﬂamma-
tory factors in chondrocytes. J. Cell.
Physiol. 197, 94–102.
Hattori, T., Kubota, S., Yutani, Y., Fuji-
sawa,T.,Nakanishi,T.,Takahashi,K.,
and Takigawa, M. (2001). Change in
cellular localization of a rheumatoid
arthritis-related antigen (RA-A47)
with downregulation upon stimula-
tion by inﬂammatory cytokines in
chondrocytes. J. Cell. Physiol. 186,
268–281.
Hattori,T.,Takahash,K.,Yutani,Y., Fuji-
sawa,T.,Nakanishi,T., andTakigawa,
M. (2000). Rheumatoid arthritis-
related antigen 47kDa (RA-A47) is
a product of colligin-2 and acts as a
humanHSP47. J. BoneMiner.Metab.
18, 328–334.
Hattori, T., Von Der Mark, K.,
Kawaki, H., Yutani, Y., Kubota,
S., Nakanishi, T., Eberspaecher, H.,
De Crombrugghe, B., and Taki-
gawa, M. (2005). Downregula-
tion of rheumatoid arthritis-related
antigen RA-A47 (HSP47/colligin-2)
in chondrocytic cell lines induces
apoptosis and cell-surface expres-
sion of RA-A47 in association with
CD9. J. Cell. Physiol. 202, 191–204.
Hauet-Broere, F.,Wieten, L.,Guichelaar,
T., Berlo, S., Van Der Zee, R., and
Van Eden, W. (2006). Heat shock
proteins induce T cell regulation of
chronic inﬂammation. Ann. Rheum.
Dis. 65(Suppl. 3), iii65–iii68.
Hebert, C., Norris, K., Della Coletta,
R., Reynolds, M., Ordonez, J.,
and Sauk, J. J. (1999). Cell sur-
face colligin/Hsp47 associates with
tetraspanin protein CD9 in epider-
moid carcinoma cell lines. J. Cell.
Biochem. 73, 248–258.
Hebert, D. N., Foellmer, B., and Hele-
nius, A. (1995). Glucose trimming
and reglucosylation determine gly-
coprotein association with calnexin
in the endoplasmic reticulum. Cell
81, 425–433.
Hershko, A., and Ciechanover, A.
(1998). The ubiquitin system. Annu.
Rev. Biochem. 67, 425–479.
Hirabayashi, Y., Oka, Y., Ikeda, T., Fujii,
H., Ishii, T., Sasaki, T., and Harigae,
H. (2010). The endoplasmic reticu-
lum stress-inducible protein, Herp,
is a potential triggering antigen for
anti-DNAresponse. J. Immunol. 184,
3276–3283.
Hirata, H., Yamamura, I., Yasuda, K.,
Kobayashi, A., Tada, N., Suzuki, M.,
Hirayoshi, K., Hosokawa, N., and
Nagata, K. (1999). Separate cis-
acting DNA elements control cell
type- and tissue-speciﬁc expression
of collagen binding molecular chap-
erone HSP47. J. Biol. Chem. 274,
35703–35710.
Hoseki, J., Ushioda, R., and Nagata,
K. (2010). Mechanism and com-
ponents of endoplasmic reticulum-
associated degradation. J. Biochem.
147, 19–25.
Hosokawa, N., Wada, I., Hasegawa, K.,
Yorihuzi, T., Tremblay, L. O., Her-
scovics, A., and Nagata, K. (2001).
A novel ER alpha-mannosidase-like
protein accelerates ER-associated
degradation.EMBORep. 2,415–422.
Isenberg, D. A., Manson, J. J., Ehren-
stein, M. R., and Rahman,A. (2007).
Fifty years of anti-ds DNA anti-
bodies: are we approaching jour-
ney’s end? Rheumatology (Oxford)
46, 1052–1056.
Ishida, Y., and Nagata, K. (2011).
Hsp47 as a collagen-speciﬁc molec-
ular chaperone. Meth. Enzymol. 499,
167–182.
Jeffery, E., Peters, L. R., and Raghavan,
M. (2011). The polypeptide bind-
ing conformation of calreticulin
facilitates its cell-surface expression
under conditions of endoplasmic
Frontiers in Immunology | Inﬂammation March 2012 | Volume 3 | Article 48 | 6
Morito and Nagata ER stress proteins in autoimmunity
reticulum stress. J. Biol. Chem. 286,
2402–2415.
Jorgensen, C., Gedon, E., Jaquet, C., and
Sany, J. (1998). Gastric administra-
tion of recombinant 65 kDa heat
shock protein delays the severity of
type II collagen induced arthritis in
mice. J. Rheumatol. 25, 763–767.
Kakugawa, T., Yokota, S., Mukae, H.,
Kubota, H., Sakamoto, N., Mizu-
noe, S., Matsuoka, Y., Kadota, J.,
Fujii, N., Nagata, K., and Kohno,
S. (2008). High serum concentra-
tions of autoantibodies to HSP47
in nonspeciﬁc interstitial pneumo-
nia compared with idiopathic pul-
monary ﬁbrosis. BMC Pulm. Med. 8,
23. doi:10.1186/1471-2466-8-23
Kamauchi, S., Nakatani, H., Nakano,
C., and Urade, R. (2005). Gene
expression in response to endoplas-
mic reticulum stress in Arabidopsis
thaliana. FEBS J. 272, 3461–3476.
Kitao, Y., Ozawa, K., Miyazaki, M.,
Tamatani, M., Kobayashi, T.,
Yanagi, H., Okabe, M., Ikawa, M.,
Yamashima, T., Stern, D. M., Hori,
O., and Ogawa, S. (2001). Expres-
sion of the endoplasmic reticulum
molecular chaperone (ORP150)
rescues hippocampal neurons from
glutamate toxicity. J. Clin. Invest.
108, 1439–1450.
Kny, M., Standera, S., Hartmann-
Petersen, R., Kloetzel, P. M., and
Seeger, M. (2011). Herp reg-
ulates Hrd1-mediated ubiquityla-
tion in a ubiquitin-like domain-
dependent manner. J. Biol. Chem.
286, 5151–5156.
Kokame, K., Agarwala, K. L., Kato,
H., and Miyata, T. (2000). Herp, a
new ubiquitin-like membrane pro-
tein induced by endoplasmic retic-
ulum stress. J. Biol. Chem. 275,
32846–32853.
Kokame, K., Kato, H., and Miy-
ata, T. (2001). Identiﬁcation of
ERSE-II, a new cis-acting ele-
ment responsible for the ATF6-
dependent mammalian unfolded
protein response. J. Biol. Chem. 276,
9199–9205.
Lilley, B. N., and Ploegh, H. L. (2004). A
membrane protein required for dis-
location of misfolded proteins from
the ER. Nature 429, 834–840.
Lilley, B. N., and Ploegh, H. L.
(2005). Multiprotein complexes that
link dislocation, ubiquitination, and
extraction of misfolded proteins
from the endoplasmic reticulum
membrane. Proc. Natl. Acad. Sci.
U.S.A. 102, 14296–14301.
Liu, B., Dai, J., Zheng, H., Stoilova,
D., Sun, S., and Li, Z. (2003).
Cell surface expression of an endo-
plasmic reticulum resident heat
shock protein gp96 triggers MyD88-
dependent systemic autoimmune
diseases. Proc. Natl. Acad. Sci. U.S.A.
100, 15824–15829.
Lu, J., Willis, A. C., and Sim, R. B.
(1993). A calreticulin-like protein
co-puriﬁes with a “60 kD” compo-
nent of Ro/SSA, but is not recog-
nized by antibodies in Sjogren’s syn-
drome sera. Clin. Exp. Immunol. 94,
429–434.
Madaio, M. P., Hodder, S., Schwartz, R.
S., and Stollar, B. D. (1984). Respon-
siveness of autoimmune and nor-
mal mice to nucleic acid antigens. J.
Immunol. 132, 872–876.
Marutani, T., Maeda, T., Tanabe, C.,
Zou, K., Araki, W., Kokame, K.,
Michikawa, M., and Komano, H.
(2011). ER-stress-inducible Herp,
facilitates the degradation of imma-
ture nicastrin. Biochim. Biophys.
Acta 1810, 790–798.
Marutani, T., Yamamoto, A., Nagai, N.,
Kubota, H., and Nagata, K. (2004).
Accumulation of type IV collagen
in dilated ER leads to apoptosis
in Hsp47-knockout mouse embryos
via induction of CHOP. J. Cell. Sci.
117, 5913–5922.
Masuda, H., Fukumoto, M., Hirayoshi,
K., and Nagata, K. (1994). Coexpres-
sion of the collagen-binding stress
protein HSP47 gene and the alpha
1(I) and alpha 1(III) collagen genes
in carbon tetrachloride-induced rat
liver ﬁbrosis. J. Clin. Invest. 94,
2481–2488.
Masuda, H., Hosokawa, N., and Nagata,
K. (1998). Expression and localiza-
tion of collagen-binding stress pro-
tein Hsp47 in mouse embryo devel-
opment: comparison with types I
and II collagen. Cell Stress Chaper-
ones 3, 256–264.
Matsuoka, Y., Kubota, H., Adachi, E.,
Nagai, N., Marutani, T., Hosokawa,
N., and Nagata, K. (2004). Insufﬁ-
cient folding of type IV collagen and
formation of abnormal basement
membrane-like structure in embry-
oid bodies derived from Hsp47-null
embryonic stem cells. Mol. Biol. Cell
15, 4467–4475.
McCauliffe, D. P., Zappi, E., Lieu, T.
S., Michalak, M., Sontheimer, R. D.,
and Capra, J. D. (1990). A human
Ro/SS-A autoantigen is the homo-
logue of calreticulin and is highly
homologous with onchocercal RAL-
1 antigen and an aplysia “mem-
ory molecule.” J. Clin. Invest. 86,
332–335.
McCracken, A. A., and Brodsky, J. L.
(1996). Assembly of ER-associated
protein degradation in vitro: depen-
dence on cytosol, calnexin, and ATP.
J. Cell Biol. 132, 291–298.
Mesaeli, N., Nakamura, K., Zvaritch, E.,
Dickie, P., Dziak, E., Krause, K. H.,
Opas, M., Maclennan, D. H., and
Michalak, M. (1999). Calreticulin is
essential for cardiac development. J.
Cell Biol. 144, 857–868.
Molinari, M., Calanca, V., Galli, C.,
Lucca, P., and Paganetti, P. (2003).
Role of EDEM in the release of mis-
folded glycoproteins from the cal-
nexin cycle. Science 299, 1397–1400.
Mori, K. (2000). Tripartite manage-
ment of unfolded proteins in the
endoplasmic reticulum. Cell 101,
451–454.
Morimoto, R. I. (1998). Regulation
of the heat shock transcriptional
response: cross talk between a fam-
ily of heat shock factors, molecular
chaperones, and negative regulators.
Genes Dev. 12, 3788–3796.
Mostoslavsky, G., Fischel, R., Yachi-
movich, N., Yarkoni, Y., Rosenmann,
E., Monestier, M., Baniyash, M., and
Eilat, D. (2001). Lupus anti-DNA
autoantibodies cross-react with a
glomerular structural protein: a case
for tissue injury by molecular mim-
icry. Eur. J. Immunol. 31, 1221–1227.
Mueller, B., Klemm, E. J., Spooner, E.,
Claessen, J. H., and Ploegh, H. L.
(2008). SEL1L nucleates a protein
complex required for dislocation of
misfolded glycoproteins. Proc. Natl.
Acad. Sci. U.S.A. 105, 12325–12330.
Mueller, B., Lilley, B. N., and Ploegh, H.
L. (2006). SEL1L, the homologue of
yeast Hrd3p, is involved in protein
dislocation from the mammalian
ER. J. Cell Biol. 175, 261–270.
Multhoff, G. (2006). Heat shock pro-
teins in immunity. Handb. Exp.
Pharmacol. 172, 279–304.
Nagai, N., Hosokawa, M., Itohara,
S., Adachi, E., Matsushita, T.,
Hosokawa, N., and Nagata, K.
(2000). Embryonic lethality of mol-
ecular chaperone hsp47 knockout
mice is associatedwith defects in col-
lagen biosynthesis. J. Cell Biol. 150,
1499–1506.
Nagata, K. (2003). HSP47 as a collagen-
speciﬁc molecular chaperone: func-
tion and expression in normal
mouse development. Semin. Cell
Dev. Biol. 14, 275–282.
Naitoh, M., Hosokawa, N., Kub-
ota, H., Tanaka, T., Shirane, H.,
Sawada, M., Nishimura, Y., and
Nagata, K. (2001). Upregulation of
HSP47 and collagen type III in
the dermal ﬁbrotic disease, keloid.
Biochem. Biophys. Res. Commun.
280, 1316–1322.
Nakatani, Y., Kaneto, H., Hatazaki,
M., Yoshiuchi, K., Kawamori, D.,
Sakamoto, K., Matsuoka, T., Ogawa,
S., Yamasaki, Y., and Matsuhisa,
M. (2006). Increased stress protein
ORP150 autoantibody production
in Type 1 diabetic patients. Diabet.
Med. 23, 216–219.
Ni, M., and Lee, A. S. (2007). ER chap-
erones in mammalian development
and human diseases. FEBS Lett. 581,
3641–3651.
Njemini, R., Bautmans, I., Onyema, O.
O., Van Puyvelde, K., Demanet, C.,
and Mets, T. (2011). Circulating heat
shock protein 70 in health, aging
and disease. BMC Immunol. 12, 24.
doi:10.1186/1471-2172-12-24
Oda, Y., Hosokawa, N., Wada, I., and
Nagata, K. (2003). EDEM as an
acceptor of terminally misfolded
glycoproteins released from cal-
nexin. Science 299, 1394–1397.
Oda, Y., Okada, T., Yoshida, H., Kauf-
man, R. J., Nagata, K., and Mori,
K. (2006). Derlin-2 and Derlin-3
are regulated by the mammalian
unfolded protein response and are
required for ER-associated degrada-
tion. J. Cell Biol. 172, 383–393.
Okazaki, Y., Ohno, H., Takase, K.,
Ochiai, T., and Saito, T. (2000). Cell
surface expression of calnexin, a
molecular chaperone in the endo-
plasmic reticulum. J. Biol. Chem.
275, 35751–35758.
Okuda-Shimizu, Y., and Hendershot, L.
M. (2007). Characterization of an
ERAD pathway for nonglycosylated
BiP substrates, which require Herp.
Mol. Cell 28, 544–554.
Orth, T., Dorner, T., Meyer Zum
Buschenfelde, K. H., and Mayet, W.
J. (1996). Complete congenital heart
block is associated with increased
autoantibody titers against calretic-
ulin. Eur. J. Clin. Invest. 26, 205–215.
Pagetta, A., Folda, A., Brunati, A. M.,
and Finotti, P. (2003). Identiﬁcation
and puriﬁcation from the plasma of
Type 1 diabetic subjects of a prote-
olytically active Grp94Evidence that
Grp94 is entirely responsible for
plasma proteolytic activity. Dia-
betologia 46, 996–1006.
Panayi, G. S., and Corrigall, V. M.
(2006). BiP regulates autoimmune
inﬂammation and tissue damage.
Autoimmun. Rev. 5, 140–142.
Rumore, P. M., and Steinman, C.
R. (1990). Endogenous circulating
DNA in systemic lupus erythemato-
sus. Occurrence as multimeric com-
plexes bound to histone. J. Clin.
Invest. 86, 69–74.
Sato, Y., Murase, K., Kato, J., Kobune,
M., Sato, T., Kawano, Y., Takimoto,
R., Takada, K., Miyanishi, K., Mat-
sunaga, T., Takayama, T., and Niitsu,
Y. (2008). Resolution of liver cir-
rhosis using vitaminA-coupled lipo-
somes to deliver siRNA against
www.frontiersin.org March 2012 | Volume 3 | Article 48 | 7
Morito and Nagata ER stress proteins in autoimmunity
a collagen-speciﬁc chaperone. Nat.
Biotechnol. 26, 431–442.
Schulte-Pelkum, J., Fritzler, M., and
Mahler, M. (2009). Latest update on
the Ro/SS-A autoantibody system.
Autoimmun. Rev. 8, 632–637.
Shoda, H., Fujio, K., Shibuya, M., Oka-
mura, T., Sumitomo, S., Okamoto,
A., Sawada, T., and Yamamoto, K.
(2011). Detection of autoantibody
to citrullinated BiP in rheuma-
toid arthritis patients and pro-
inﬂammatory roles of citrullinated
BiP in collagen-induced arthritis.
Arthritis Res. Ther. 13, R191.
Smith, M. H., Ploegh, H. L., and Weiss-
man, J. S. (2011). Road to ruin: tar-
geting proteins for degradation in
the endoplasmic reticulum. Science
334, 1086–1090.
Staikou, E. V., Routsias, J. G., Makri,
A. A., Terzoglou, A., Sakarellos-
Daitsiotis, M., Sakarellos, C., Panay-
otou, G., Moutsopoulos, H. M., and
Tzioufas, A. G. (2003). Calreticulin
binds preferentially with B cell lin-
ear epitopes of Ro60 kD autoanti-
gen, enhancing recognition by anti-
Ro60 kD autoantibodies. Clin. Exp.
Immunol. 134, 143–150.
Suzuki, A., Yamada, R., and Yamamoto,
K. (2007). Citrullination by peptidy-
larginine deiminase in rheumatoid
arthritis. Ann. N. Y. Acad. Sci. 1108,
323–339.
Suzuki, S., Utsugisawa, K., Iwasa, K.,
Satoh, T., Nagane, Y., Yoshikawa,
H., Kuwana, M., and Suzuki, N.
(2011). Autoimmunity to endoplas-
mic reticulum chaperone GRP94 in
myasthenia gravis. J. Neuroimmunol.
237, 87–92.
Todd, D. J., Lee, A. H., and Glimcher, L.
H. (2008). The endoplasmic reticu-
lum stress response in immunity and
autoimmunity. Nat. Rev. Immunol.
8, 663–674.
Tsai, B., Ye, Y., and Rapoport, T. A.
(2002). Retro-translocation of pro-
teins from the endoplasmic reticu-
lum into the cytosol. Nat. Rev. Mol.
Cell Biol. 3, 246–255.
Tsukamoto, Y., Kuwabara, K., Hirota, S.,
Ikeda, J., Stern, D., Yanagi, H., Mat-
sumoto, M., Ogawa, S., and Kita-
mura, Y. (1996). 150-kD oxygen-
regulated protein is expressed in
human atherosclerotic plaques and
allows mononuclear phagocytes to
withstand cellular stress on exposure
to hypoxia and modiﬁed low den-
sity lipoprotein. J. Clin. Invest. 98,
1930–1941.
Tu, B. P., and Weissman, J. S.
(2004). Oxidative protein folding in
eukaryotes: mechanisms and conse-
quences. J. Cell Biol. 164, 341–346.
Ushioda,R.,Hoseki, J.,Araki, K., Jansen,
G., Thomas, D. Y., and Nagata, K.
(2008). ERdj5 is required as a disul-
ﬁde reductase for degradation of
misfolded proteins in the ER. Science
321, 569–572.
Ushioda, R., and Nagata, K. (2011). The
endoplasmic reticulum-associated
degradation and disulﬁde reduc-
tase ERdj5. Meth. Enzymol. 490,
235–258.
van Eden, W., Thole, J. E., Van Der
Zee, R., Noordzij, A., Van Embden,
J. D., Hensen, E. J., and Cohen, I. R.
(1988). Cloning of the mycobacter-
ial epitope recognized by T lympho-
cytes in adjuvant arthritis. Nature
331, 171–173.
Van Eden, W., Wick, G., Albani, S., and
Cohen, I. (2007). Stress, heat shock
proteins, and autoimmunity: how
immune responses to heat shock
proteins are to be used for the con-
trol of chronic inﬂammatory dis-
eases. Ann. N. Y. Acad. Sci. 1113,
217–237.
van Venrooij, W. J., Van Beers, J. J.,
and Pruijn, G. J. (2011). Anti-CCP
antibodies: the past, the present and
the future. Nat. Rev. Rheumatol. 7,
391–398.
Vincent, C., Nogueira, L., Clavel, C.,
Sebbag, M., and Serre, G. (2005).
Autoantibodies to citrullinated pro-
teins: ACPA. Autoimmunity 38,
17–24.
Vossenaar, E. R., Zendman, A. J., Van
Venrooij, W. J., and Pruijn, G. J.
(2003). PAD, a growing family of cit-
rullinating enzymes: genes, features
and involvement indisease.Bioessays
25, 1106–1118.
Voynova, E. N., Tchorbanov, A. I.,
Todorov, T. A., and Vassilev, T.
L. (2005). Breaking of tolerance
to native DNA in nonautoimmune
mice by immunization with natural
protein/DNA complexes. Lupus 14,
543–550.
Wada, I., Kai, M., Imai, S., Sakane, F.,
and Kanoh,H. (1997). Promotion of
transferrin folding by cyclic interac-
tions with calnexin and calreticulin.
EMBO J. 16, 5420–5432.
Wada, I., Rindress, D., Cameron, P. H.,
Ou, W. J., Doherty, J. J. II, Lou-
vard, D., Bell, A. W., Dignard, D.,
Thomas, D. Y., and Bergeron, J. J.
(1991). SSR alpha and associated
calnexin are major calcium binding
proteins of the endoplasmic reticu-
lum membrane. J. Biol. Chem. 266,
19599–19610.
Walter, P., and Ron, D. (2011). The
unfolded protein response: from
stress pathway to homeostatic reg-
ulation. Science 334, 1081–1086.
Wanderling, S., Simen, B. B., Ostro-
vsky, O., Ahmed, N. T., Vogen, S.
M., Gidalevitz, T., and Argon, Y.
(2007). GRP94 is essential for meso-
derm induction and muscle devel-
opment because it regulates insulin-
like growth factor secretion. Mol.
Biol. Cell 18, 3764–3775.
Watanabe, K., Ohira, H., Orikasa, H.,
Saito, K., Kanno, K., Shioya, Y.,
Obara, K., and Sato, Y. (2006). Anti-
calreticulin antibodies in patients
with inﬂammatory bowel disease.
Fukushima J. Med. Sci. 52, 1–11.
Weber, C. K., Haslbeck, M., Englbrecht,
M., Sehnert, B., Mielenz, D., Graef,
D., Distler, J. H., Mueller, R.
B., Burkhardt, H., Schett, G.,
Voll, R. E., and Furnrohr, B. G.
(2010). Antibodies to the endo-
plasmic reticulum-resident chaper-
ones calnexin, BiP and Grp94 in
patients with rheumatoid arthri-
tis and systemic lupus erythe-
matosus. Rheumatology (Oxford) 49,
2255–2263.
Wendling, U., Paul, L., Van Der Zee,
R., Prakken, B., Singh, M., and
Van Eden, W. (2000). A conserved
mycobacterial heat shock protein
(hsp) 70 sequence prevents adjuvant
arthritis upon nasal administration
and induces IL-10-producing T cells
that cross-reactwith themammalian
self-hsp70 homologue. J. Immunol.
164, 2711–2717.
Williams, D. B. (2006). Beyond
lectins: the calnexin/calreticulin
chaperone system of the endoplas-
mic reticulum. J. Cell. Sci. 119,
615–623.
Yagishita, N., Yamasaki, S., Nishioka, K.,
and Nakajima, T. (2008). Synovio-
lin, protein folding and the main-
tenance of joint homeostasis. Nat.
Clin. Pract. Rheumatol. 4, 91–97.
Yamamura, I., Hirata, H., Hosokawa,
N., and Nagata, K. (1998). Tran-
scriptional activation of the mouse
HSP47 gene in mouse osteoblast
MC3T3-E1 cells by TGF-beta 1.
Biochem. Biophys. Res. Commun.
244, 68–74.
Yasuda, K., Hirayoshi, K., Hirata, H.,
Kubota, H., Hosokawa, N., and
Nagata, K. (2002). The Kruppel-
like factor Zf9 and proteins in the
Sp1 family regulate the expression
of HSP47, a collagen-speciﬁc mol-
ecular chaperone. J. Biol. Chem. 277,
44613–44622.
Ye, Y., Meyer, H. H., and Rapoport, T. A.
(2001). The AAA ATPase Cdc48/p97
and its partners transport proteins
from the ER into the cytosol. Nature
414, 652–656.
Ye, Y., Meyer, H. H., and Rapoport,
T. A. (2003). Function of the p97-
Ufd1-Npl4 complex in retrotranslo-
cation from the ER to the cytosol:
dual recognition of nonubiquiti-
nated polypeptide segments and
polyubiquitin chains. J. Cell Biol.
162, 71–84.
Yokota, S., and Fujii, N. (2010).
Immunomodulatory activity of
extracellular heat shock proteins
and their autoantibodies. Microbiol.
Immunol. 54, 299–307.
Yokota, S., Kubota, H., Matsuoka, Y.,
Naitoh, M., Hirata, D., Minota, S.,
Takahashi, H., Fujii, N., and Nagata,
K. (2003). Prevalence of HSP47 anti-
gen and autoantibodies to HSP47 in
the sera of patients with mixed con-
nective tissue disease. Biochem. Bio-
phys. Res. Commun. 303, 413–418.
Yoshida, H. (2007). ER stress and dis-
eases. FEBS J. 274, 630–658.
Yoshida, H., Haze, K., Yanagi, H., Yura,
T., and Mori, K. (1998). Iden-
tiﬁcation of the cis-acting endo-
plasmic reticulum stress response
element responsible for transcrip-
tional induction of mammalian
glucose-regulated proteins. Involve-
ment of basic leucine zipper tran-
scription factors. J. Biol. Chem. 273,
33741–33749.
Conﬂict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
could be construed as a potential con-
ﬂict of interest.
Received: 15December 2011; paper pend-
ing published: 10 January 2012; accepted:
28 February 2012; published online: 15
March 2012.
Citation: Morito D and Nagata K (2012)
ER stress proteins in autoimmune and
inﬂammatory diseases. Front. Immun.
3:48. doi: 10.3389/ﬁmmu.2012.00048
This article was submitted to Frontiers in
Inﬂammation, a specialty of Frontiers in
Immunology.
Copyright © 2012 Morito and Nagata.
This is an open-access article distributed
under the terms of the Creative Commons
Attribution Non Commercial License,
which permits non-commercial use, dis-
tribution, and reproduction in other
forums, provided the original authors and
source are credited.
Frontiers in Immunology | Inﬂammation March 2012 | Volume 3 | Article 48 | 8
